Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer

被引:0
|
作者
Haricharan, Svasti [1 ]
Punturi, Nindo [1 ]
Seker, Sinem [1 ]
Devarakonda, Vaishnavi [2 ]
Kalra, Rashi [2 ]
Chen, Ching-Hui [2 ]
Mazumder, Aloran [1 ]
Li, Shungqiang [3 ]
Primeau, Tina [3 ]
Ellis, Matthew [2 ]
Kavuri, Shyam [2 ]
机构
[1] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Washington Univ, St Louis, MO 63110 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PD8-05
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients
    Yuji Mishima
    Satoshi Matsusaka
    Keisho Chin
    Mariko Mikuniya
    Sayuri Minowa
    Tomoko Takayama
    Harumi Shibata
    Ryoko Kuniyoshi
    Mariko Ogura
    Yasuhito Terui
    Nobuyuki Mizunuma
    Kiyohiko Hatake
    Targeted Oncology, 2017, 12 : 341 - 351
  • [42] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    de Moura Leite, Luciana
    Cesca, Marcelle Goldner
    Tavares, Monique Celeste
    Santana, Debora Maciel
    Saldanha, Erick Figueiredo
    Guimaraes, Paula Tavares
    Sa, Daniella Dias Silva
    Simoes, Maria Fernanda Evangelista
    Viana, Rafael Lima
    Rocha, Francisca Giselle
    Loose, Simone Klog
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla Albina Zanco
    Mattos, Bruna Raphaeli Silva
    Campos, Fernando Augusto Batista
    Sanches, Solange Moraes
    de Lima, Vladmir Claudio Cordeiro
    Ponde, Noam Falbel
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (01) : 155 - 163
  • [43] HER2-low breast cancer shows a lower immune response compared to HER2-negative cases
    van den Ende, Nadine S.
    Smid, Marcel
    Timmermans, Annemieke
    van Brakel, Johannes B.
    Hansum, Tim
    Foekens, Renee
    Trapman, Anita M. A. C.
    Heemskerk-Gerritsen, Bernadette A. M.
    Jager, Agnes
    Martens, John W. M.
    van Deurzen, Carolien H. M.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [44] The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer
    Wei Wang
    Tingting Zhu
    Hao Chen
    Yongzhong Yao
    Clinical and Translational Oncology, 2023, 25 : 1673 - 1681
  • [45] Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients
    Mishima, Yuji
    Matsusaka, Satoshi
    Chin, Keisho
    Mikuniya, Mariko
    Minowa, Sayuri
    Takayama, Tomoko
    Shibata, Harumi
    Kuniyoshi, Ryoko
    Ogura, Mariko
    Terui, Yasuhito
    Mizunuma, Nobuyuki
    Hatake, Kiyohiko
    TARGETED ONCOLOGY, 2017, 12 (03) : 341 - 351
  • [46] HER2 equivocal breast cancer that is positive by alternative probe HER2 FISH are classified as HER2 negative by Oncotype DX
    Tozbikian, Gary H.
    Zynger, Debra L.
    BREAST JOURNAL, 2018, 24 (04) : 535 - 540
  • [47] Safety and effectiveness of anti-HER2 therapy in patients with advanced metastatic tissue HER2-negative breast cancer with elevated serum HER2 and/or HER2 overexpressing circulating tumor cells
    Kurbacher, C. M.
    Eichler, C.
    Quade, A. B.
    Kunstmann, G.
    Herz, S.
    Kurbacher, J. A.
    Warm, M. R.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S40 - S40
  • [48] Programmed death-ligand 1 expression in gastric cancer: correlation with mismatch repair deficiency and HER2-negative status
    Wang, Lei
    Zhang, Qiongyan
    Ni, Shujuan
    Tan, Cong
    Cai, Xu
    Huang, Dan
    Sheng, Weiqi
    CANCER MEDICINE, 2018, 7 (06): : 2612 - 2620
  • [49] Gene panel predicts neoadjuvant chemoimmunotherapy response and benefit from immunotherapy in HER2-negative breast cancer
    Lu, Xunxi
    Gou, Zongchao
    Chen, Hong
    Li, Li
    Chen, Fei
    Bao, Chunjuan
    Bu, Hong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (08) : 1 - 13
  • [50] Programmed Death-Ligand 1 Expression in Gastric Cancer: Correlation with Mismatch Repair Deficiency and HER2-Negative Status
    Wang, Lei
    Zhao, Shengnan
    Ni, Shujuan
    Tan, Cong
    Huang, Dan
    Sheng, Weigi
    LABORATORY INVESTIGATION, 2017, 97 : 205A - 205A